ClinicalTrials.Veeva

Menu

Cardiac Output Monitoring by ccNexfin© in Pregnant Women (CoNex)

U

University Hospital, Lille

Status

Completed

Conditions

Pregnancy

Treatments

Device: cardiac output by ccNexfin ©

Study type

Interventional

Funder types

Other

Identifiers

NCT03735043
2017_54
2018-A01089-46 (Other Identifier)

Details and patient eligibility

About

Variations of cardiac output are frequent in pregnant women during obstetrical procedures, and may participate to poor foetal outcomes through decrease of uteroplacental bloodflow. Thus, monitoring maternal cardiac output appears of major interest, as it would open the way to early initiation of hemodynamic supportive management.

The ccNexfin© is a non-invasive hemodynamic monitoring device, whose relevance for continuous monitoring of cardiac output has been reported in a non-pregnant population.

The hypothesis is that ccNexfin© gives acceptable measurement of maternal cardiac output in pregnant women.

Enrollment

100 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Pregnancy > 32 weeks of amenorrhea
  • Informed consent to participate to the study
  • Health insurance

Exclusion Criteria:

  • Poor echogenicity for Transthoracic echocardiography
  • Cardiopathy
  • Difficulties to move
  • Necessity of strict supine or lateral position
  • Impossibility to receive information or to give inform consent to participate to the study Refusal to sign inform consent

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

ccNexfin ©
Experimental group
Treatment:
Device: cardiac output by ccNexfin ©

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems